Volume increased significantly during the quarter. Revenue declined 2 percent due to currency effects and the divestment of the Primary Amides business. Demand in Europe was better than last year and general market conditions improved in North America. The Ethylene Amine market remains stable. The benefits of the restructuring program that was announced in 2013, are coming through.